強
強気
強気 · 25%SXTC
$2.24
シナリオ価格
$0.048
-0.016 (-34.25%)終値時点
Loading chart…
- 高値
- 0.051
- 始値
- 0.051
- 出来高加重平均価格
- 0.05
- 出来高
- 57.49M
- 時価総額
- 1.01M
- 安値
- 0.045
- 売買代金
- 2.77M
- EV/EBITDA（TTM）
- 0.00
China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang.
AI分析 of China SXT Pharmaceuticals Inc (SXTC)
売りGiven the current price of $0.07 and an RSI of 27.828 indicating oversold conditions, SXTC appears to be a risky investment. The stock has experienced a staggering 100% decline year-to-date, and the recent 1-for-150 reverse stock split has not stabilized the share price, which is currently well below the Nasdaq's minimum bid requirement of $1. The main risk is the company's negative earnings with a P/E ratio of -0.082626, reflecting ongoing financial struggles.
バリュエーション指標
China SXT Pharmaceuticals Inc（SXTC）の現在の予想PERは0.00で、5年平均は0.00です。
Alphio AI による SXTC の価格シナリオ
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト（25 / 50 / 25）であり、保証ではありません。
イベントタイムライン
ニュース
8.510-09NewsfilterChina SXT Pharmaceuticals Closes $12 Million Direct Offering
8.510-08PRnewswireChina SXT Pharmaceuticals Announces Direct Offering of 8 Million Shares
- 8.507-24Newsfilter
China SXT Pharmaceuticals Closes $9 Million Direct Offering
8.507-23seekingalphaChina SXT Pharmaceuticals Secures $9M Direct Offering
9.502-02BenzingaDarkIris Inc Reports 27.3% Revenue Growth, Shares Surge
SXTC のよくある質問 — Alphio AI が回答
China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).
Given the current price of $0.07 and an RSI of 27.828 indicating oversold conditions, SXTC appears to be a risky investment. The stock has experienced a staggering 100% decline year-to-date, and the recent 1-for-150 reverse stock split has not stabilized the share price, which is currently well below the Nasdaq's minimum bid requirement of $1. The main risk is the company's negative earnings with a P/E ratio of -0.082626, reflecting ongoing financial struggles.
コミュニティ
もっと見る ↗
$GNPX October 2024 and October 2025. Two Octobers in a row produced strong rallies, and anyone who has followed GNPX closely would recognize that. In 2024 the month finished up about 522%...... The sample is two years, both moves were tied to a thin float, and the current float is even smaller than it was over the last two years, so it may be worth watching for a trade. For that reason, I mentioned GNPX as a potential $SXTC type mover. Let's see what this month brings.
もっと見る
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。